Cathie Wood's ARK Innovation Stocks Performance Guide: Beam Therapeutics (BEAM)
BEAM has no dividends.
Table and Chart of BEAM Performance
See what a $1,000 investment in BEAM is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| BEAM Returns | |
|---|---|
| Start Date | Mar-31-2020 |
| Start Price | $18.00 |
| End Date | May-17-2024 |
| End Price | $24.62 |
| # Prices | 51 |
| Min Date | Apr-30-2020 |
| Min Price | $15.95 |
| Max Date | Jun-30-2021 |
| Max Price | $128.71 |
| Total Return | 36.78% |
| Annualized Return | 7.65% |
| Current Value of $1,000 Purchase | $1,368 |
| Number Returns | 1,275 |
| Average Return | 15.00% |
| Number Profitable Returns | 459 |
| Percent Profitable Returns | 36.00% |
| Number Unprofitable Returns | 816 |
| Percent Unprofitable Returns | 64.00% |
| Profitable to Unprofitable Returns Ratio | 0.56 |
| BEAM Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,026,499,000 |
| Beta | 1.877 | Price to Sales | 5.61 |
| Earnings per Share | $-1.6000 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 2.158 |
| PRICE DATA | |
| 52 Week High | $49.5 |
| 52 Week Low | $16.95 |
| Analyst Target Price | $48.67 |
| 50-Day Moving Average | $27.84 |
| 200-Day Moving Average | $26.69 |
| FINANCIAL DATA | |
| Revenue per Share | $4.539 |
| Revenue | $360,911,000 |
| Profit Margin | -37.3% |
| Return on Equity | -16.1% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
BEAM Compare Returns with S&P 500
BEAM Trendline Chart
BEAM Moving Average Chart
BEAM Stock Return Map - See Patterns of Gains and Losses
BEAM Stock Returns/Purchase Dates